Lentigines Including Lentigo Simplex, Reticulated Lentigo and Actinic Lentigo V.3 Paolo Carli and Camilla Salvini

Total Page:16

File Type:pdf, Size:1020Kb

Lentigines Including Lentigo Simplex, Reticulated Lentigo and Actinic Lentigo V.3 Paolo Carli and Camilla Salvini Chapter V.3 Lentigines Including Lentigo Simplex, Reticulated Lentigo and Actinic Lentigo V.3 Paolo Carli and Camilla Salvini Contents V.3.1 Simple Lentigo V.3.1 Simple Lentigo. .290 The definition of lentigo simplex (or lentigo V.3.1.1 Definition . .290 simplex) is a common brown melanocytic le- V.3.1.2 Clinical Features . .290 sion, considered to be the precursor of junction- V.3.1.3 Dermoscopic Criteria. 291 al melanocytic nevi. V.3.1.4 Relevant Clinical Differential Diagnosis. 291 V.3.1.5 Histopathology. .291 V.3.1.6 Management. .292 V.3.1.1 Definition V.3.2 Ink-Spot Lentigo . .292 Lentigines are macular increases in melanin V.3.2.1 Definition . .292 pigmentation of the skin that are persistently V.3.2.2 Clinical Features . .292 present. Histopathologically, they show an in- V.3.2.3 Dermoscopic Criteria. 292 crease in the number of melanocytes at the der- V.3.2.4 Relevant Clinical Differential mo-epidermal junction. Lentigines can be clas- Diagnosis. 292 sified in accordance with aetiological factors V.3.2.5 Histopathology. .293 (Table V.3.1). V.3.2.6 Management. .293 V.3.3 Actinic Lentigo. .293 V.3.3.1 Definition . .293 V.3.1.2 Clinical Features V.3.3.2 Clinical Features . .293 Macular area of light-brown or brown-black V.3.3.3 Dermoscopic Criteria. 293 pigmentation, fairly uniform, usually circu- V.3.3.4 Relevant Clinical Differential lar or oval, with 3–5 mm in diameter, although Diagnosis. 293 several individual lentigines may coalesce V.3.3.5 Histopathology. .294 (Fig. V.3.1). Lentigines may occur in any area of V.3.3.6 Management. .294 the skin, the muco-cutaneous junctions or the References. .294 conjunctive. They are very common, particu- larly in persons with red hair and skin type I– II. V.3 Chapter V.3 Lentigines Chapter V.3 291 Lentigines Including Lentigo Simplex, Table V.3.1. Classification of lentigines Lentigines associated Lentigines not associated Lentigines as characteristic Reticulated Lentigo and Actinic Lentigo V.3 with excessive exposure with excessive exposure feature of multisystem to UV radiation to UV radiation syndromes Paolo Carli and Camilla Salvini Lentigo simplex (juvenile lentigo) Genital lentiginosis Centrofacial lentiginosis Reticular lentigo (ink-spot lentigo) Labial lentigo LEOPARD syndrome (or multiple lentigines syndrome) Actinic (solar) lentigo Oral lentiginosis Laugier−Hunzinger syndrome Photochemotherapy (PUVA) lentigo Peutz−Jeghers syndrome Sunbeds lentigo Cardiac myoma syndrome Fig. V.3.1. Lentigo simplex (clinical photo) Fig. V.3.2. Lentigo simplex (dermoscopic photo) V.3.1.3 Dermoscopic Criteria V.3.1.5 Histopathology On dermoscopy, lentigo simplex appears with a There is a linear increase in the number of me- typical brown or brown-black network, with lanocytes along the dermo-epidermal junction thin pattern and uniformly arranged stitches without melanocytes in the dermis. The in- (Fig. V.3.2). This profile is due to the elongated creased pigmentation is due both to melanin in and hyperpigmented epidermal ridges [1]. the epidermis and stratum corneum, and to the presence of melanophages in the papillary der- mis. The papillary and interpapillary ridges are V.3.1.4 Relevant Clinical Differential usually elongated. Diagnosis Lentigines are distinguished from ephelides by the fact that they have no connection with sun- light: they do not darken or increase in number upon sun exposure. 292 P. Carli, C. Salvini V.3.1.6 Management As they have no increased risk for malignancy than common nevi, the patient should be reas- sured. Laser therapy may be effective if the pa- tient requests treatment for aesthetic reasons. V.3.2 Ink-Spot Lentigo V.3.2.1 Definition The ink-spot lentigo or reticulated lentigo (re- ticulated black solar lentigo, reticular lentigo, acquired reticulated lentigo, reticulated mela- Fig. V.3.3. Reticulated lentigo (clinical image) notic macule) is a small (<5 mm in diameter) black macula, usually on sun-exposed areas. It occurs more frequently in adult men, and the most involved sites are chest and upper back [2]. It is a rare variant of lentigo, which is particu- larly important because clinically it may be con- fused with melanoma in situ. V.3.2.2 Clinical Features It is a brown-black lesion with a wiry or bead- ed appearance and a markedly irregular outline (Fig. V.3.3). The lesion is limited to sun-exposed areas of the body and it is usually solitary with near numerous solar lentigines. It affects mainly fair-skinned individuals with skin types I and II. Fig. V.3.4. Reticulated lentigo (dermoscopic image) V.3.2.3 Dermoscopic Criteria V.3.2.4 Relevant Clinical Differential Diagnosis Although ink-spot lentigo may be a cause of concern for both doctor and patient, due to its black pigmentation, dermoscopic examination Because of its dark colour and irregular border, shows a peculiar pattern of benignity; therefore, the ink-spot lentigo is often considered to be V.3 in the majority of cases, dermoscopy enables the suspicious for melanoma; however, the clinically clinician to achieve a correct non-invasive clas- and dermoscopically special pathognomonic sification of this lesion without the need of veri- features allow to make the diagnosis of a benign fication biopsy. Dermoscopic features are those lentigo. of a peculiar type of prominent (black to dark brown), broken-up network, which allows im- mediate diagnosis of ink spot lentigo (Fig. V.3.4) [3]. Lentigines Chapter V.3 293 V.3.2.5 Histopathology The histopathology of the lesion shows lentigi- nous hyperplasia of the epidermis, very marked basal cell hyperpigmentation, rete-tip accentua- tion and characteristic acromic skip areas. The melanocytes, without cytological atypia, may be normal or minimally increased in number. V.3.2.6 Management The lesion is completely benign (although the features may sometimes be clinically worri- Fig. V.3.5. Actinic lentigo of the hand some) and no treatment is required. V.3.3 Actinic Lentigo V.3.3.1 Definition Actinic lentigo (or solar lentigo or lentigo senilis or senile freckle or liver spot) is characterized clinically by a macular and tan-coloured lesion arising on sun-exposed sites, usually larger than 6 mm in size and with striking irregular bor- ders. Histologically, it is classified as early seb- orrhoeic keratoses. Fig. V.3.6. Actinic lentigo (dermoscopic image) V.3.3.2 Clinical Features Actinic lentigines are benign, irregular macula like” edge. On the face dermoscopy reveals spe- and vary from light to dark brown in colour cific criteria according to the particular histo- (Fig. V.3.5). Their size is variable from 0.1 to logical architecture shown by sun-damaged 1 cm or more in diameter and they have a ten- skin. The pigmentation gives rise to a diffuse dency to coalesce. They are associated with cu- coloration with circular hypopigmented follicu- mulative and intermittent sun exposure, with lar openings, called pseudo-network (like in history of sunburns in childhood and with cuta- seborrhoeic keratoses) [4]. neous signs of photodamage. In younger patients they are commonly numerous on face and shoul- ders, whereas in older subjects they appear on V.3.3.4 Relevant Clinical Differential the face, the backs of the hands and forearms. Diagnosis On the face lentigo maligna may be clinically V.3.3.3 Dermoscopic Criteria mistaken for actinic lentigines [5]. Sometimes lentigo maligna and actinic lentigo may have On dermoscopy, actinic lentigo appears with a clinically the same characteristics: regular and homogeneous pattern and coloration is largely homogeneous appearance and small size, lack- uniform (brown/tan; Fig. V.3.6). Commonly ing the ABCD signs of malignancy. All these le- they have a particular “moth-eaten” or “jelly- sions have been shown to benefit from the use of 294 P. Carli, C. Salvini dermoscopy [6]. Dermoscopy discovers the real References nature of the lesions, revealing the presence of criteria diagnostic for actinic lentigo/early seb- 1. Argenziano G, Soyer HP, Giorgi V de et al. (2000) orrhoeic keratoses, or for early-stage lentigo Atlante interattivo di dermatoscopia. Edra Medical maligna (see Chap. IV.7). Publishing and New Media, Italy CD-ROM 2. Bolognia JL (1992) Reticulated black solar lentigo (“ink spot” lentigo). Arch Dermatol 128: 934–940 3. Argenziano G (2004) Dermoscopy of melanocytic V.3.3.5 Histopathology hyperplasias. Subpatterns of lentigines (ink spot). Arch Dermatol 140:776 There is a linear increase of melanocytes at the 4. Gasparini S, Giovene GL, Ferranti G (2003) Trattato dermo-epidermal junction, but no cytological di dermatoscopia. Sprinter-Verlag, Berlin Heidelberg atypia is present. There is frequently associated New York 5. Stante M, Giorgi V de, Stanganelli I et al. (2005) Der- solar elastosis and there may be slight hyper- moscopy for early detection of facial lentigo maligna. keratosis. The epidermis appears with extension Br J Dermatol 152:361–364 of the rete ridges to form bud-like processes ex- 6. Moreno-Ramirez D, Ferrandiz L, Camacho FM panding into the papillary dermis. (2005) Are the ABCD signs useful for the manage- ment of solar lentigo? Br J Dermatol 153: 1083–1084 V.3.3.6 Management Like the other lentigines, these lesions are be- nign and, for this reason, they do not need treat- ment. If a patient requires treatment for aesthet- ic reasons, either laser therapy or cryotherapy may be effective. C Core Messages ■ Lentigines are persistently present macular increases in melanin pigmen- tation of the skin. ■ Lentigo simplex appears dermoscopi- cally with a brown or brown-to-black network with a thin pattern and uniformly arranged stitches. ■ Ink-spot lentigo can clinically give the impression of being melanoma.
Recommended publications
  • Melanocytes and Their Diseases
    Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Melanocytes and Their Diseases Yuji Yamaguchi1 and Vincent J. Hearing2 1Medical, AbbVie GK, Mita, Tokyo 108-6302, Japan 2Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Correspondence: [email protected] Human melanocytes are distributed not only in the epidermis and in hair follicles but also in mucosa, cochlea (ear), iris (eye), and mesencephalon (brain) among other tissues. Melano- cytes, which are derived from the neural crest, are unique in that they produce eu-/pheo- melanin pigments in unique membrane-bound organelles termed melanosomes, which can be divided into four stages depending on their degree of maturation. Pigmentation production is determined by three distinct elements: enzymes involved in melanin synthesis, proteins required for melanosome structure, and proteins required for their trafficking and distribution. Many genes are involved in regulating pigmentation at various levels, and mutations in many of them cause pigmentary disorders, which can be classified into three types: hyperpigmen- tation (including melasma), hypopigmentation (including oculocutaneous albinism [OCA]), and mixed hyper-/hypopigmentation (including dyschromatosis symmetrica hereditaria). We briefly review vitiligo as a representative of an acquired hypopigmentation disorder. igments that determine human skin colors somes can be divided into four stages depend- Pinclude melanin, hemoglobin (red), hemo- ing on their degree of maturation. Early mela- siderin (brown), carotene (yellow), and bilin nosomes, especially stage I melanosomes, are (yellow). Among those, melanins play key roles similar to lysosomes whereas late melanosomes in determining human skin (and hair) pigmen- contain a structured matrix and highly dense tation.
    [Show full text]
  • Senile Lentigo – Cosmetic Or Medical Issue of the Elderly Population
    Coll. Antropol. 34 (2010) Suppl. 2: 85–88 Original scientific paper Senile Lentigo – Cosmetic or Medical Issue of the Elderly Population Mirna [itum1, Vedrana Bulat1, Marija Buljan1, Zvonimir Puljiz2, V. [itum3 and @eljana Bolan~a1 1 Department of Dermatology and Venereology, University Hospital »Sestre Milosrdnice«, Zagreb, Croatia 2 Department of General Surgery, University Hospital »Sestre milosrdnice«, Zagreb, Croatia 3 Department of General Practice, Split, Croatia ABSTRACT Senile lentigo or age spots are hyperpigmented macules of skin that occur in irregular shapes, appearing most com- monly in the sun- exposed areas of the skin such as on the face and back of the hands. Senile lentigo is a common compo- nent of photoaged skin and is seen most commonly after the age of 50. There are many disscusions on whether senile lentigo represents a melanoma precursor, namely lentigo maligna melanoma and, if there is a need for a regular follow up in cases of multiple lesions. Clinical opservations sometimes report that in the location of the newly diagnosed mela- noma, such lesion preexsisted. On contrary, some authors believe that senile lentigo represents a precursor of seborrheic keratosis, which does not require a serious medical treatment. However, the opservation of the possible association of se- nile lentigo with the melanoma development makes us cautious in the assessment of this lesion. Histologically, there are elongated rete ridges with increased melanin at the tips, and the number of melanocytes is not increased. The dermato- scopic features are also distinctive. If the lesion becomes inflammed it may evolve into benign lichenoid keratosis. Cryo- therapy and laser treatment are common therapeutic approaches.
    [Show full text]
  • Critical Evaluation of the So-Called “Junction Nevus”
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector CRITICAL EVALUATION OF THE SO-CALLED "JUNCTION NEVUS* S. WILLIAM BECKER, MS., M.D. The serious study of pigmented nevi was undertaken by many workers in the closing years of the 19th Century. All recognized that the microscopic picture of nevi differed from anything seen in other organs. The presence of nevus cells in both the epidermis and dermis led to concepts of origin at one or the other site, or at both sites. Dermal Origin: Demieville (1) believed that the nevus cells arose from adven- titial and endothelial cells of blood vessels. Bauer (2) and vonRecklinghausen (3) thought that the origin was from endothelium of lymph vessels rather than of blood vessels. Epidermal Origin: According to Abesser (4), Duranti, in 1871, was the first to suggest an epidermal origin of nevus cells. Kromayer (5) stated that the endo- thelium-like cells originate in the basal portion of the epidermis as "Bläschen- zellen", migrate to the dermis and develop connective tissue and elastic fibers, a change which he called "desmoplasia". Abesser (4) agreed that the cells origi- ated in the epithelium and lost their intercellular bridges, but migrated into the dermis as epithelium-like cells, and remained such. Unna (6) advanced the concept that the epithelial cells changed by losing their intercellular bridges and multiplied in groups, a process which he called "Ab- sonderung", then migrated as groups to the dermis, which he called "Abtrop- fung", thus forming pigmented nevi.
    [Show full text]
  • Dermatology DDX Deck, 2Nd Edition 65
    63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83.
    [Show full text]
  • Diagnostic Pitfall of Localized Lentigo Accompanied by Post-Inflammatory
    Letter to the Editor Diagnostic pitfall of localized lentigo accompanied by post-inflammatory pigmentation on the palm with a several-month history Keisuke Imafuku, Hiroo Hata, Shinya Kitamura, Toshifumi Nomura, Hiroshi Shimizu Department of Dermatology, Hokkaido University Graduate School of MedicineNorth 15, West 7, Kita-ku, Sapporo 060- 8638, Japan Corresponding author: Dr. Hiroo Hata, MD, PhD, E-mail: [email protected] Sir, When dermatologists see acquired and well- circumscribed pigmented macules on the palm, dorsal hand or forearm of the elderly, they tend to consider blue nevus, hematoma, nevus cell nevus and malignant melanoma as differential diagnoses [1]. We a b herein described the very rare case of localized lentigo Figure 1: Clinical manifestations. a. The macule is brown to dark black, accompanied by post-inflammatory pigmentation well-demarcated, flat, round and 3 x 4 mm in size. b. Dermoscopy of the macule shows homogenous brownish pigmentation without the in a patient who has been treated for palmoplanter parallel ridge or furrow pattern that is commonly observed in acral pustulosis for a long time. This eruption mimicked lentiginous lesion some kinds of lentiginous lesion and it was difficult to diagnose clinically. A 59-year-old female was referred to our hospital with a pigmented macule on her left palm. She had been to the family doctor for treatment of palmoplanter pustulosis by topical steroid ointment application for several years. According to the a history-taking interview, she said that the lesion had b appeared 5 months before referral to our hospital as a tiny pigmented macule and had gradually enlarged during those 5 months (Fig.
    [Show full text]
  • Phacomatosis Spilorosea Versus Phacomatosis Melanorosea
    Acta Dermatovenerologica 2021;30:27-30 Acta Dermatovenerol APA Alpina, Pannonica et Adriatica doi: 10.15570/actaapa.2021.6 Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis Daniele Torchia1 ✉ 1Department of Dermatology, James Paget University Hospital, Gorleston-on-Sea, United Kingdom. Abstract Introduction: Phacomatosis pigmentovascularis is a term encompassing a group of disorders characterized by the coexistence of a segmental pigmented nevus of melanocytic origin and segmental capillary nevus. Over the past decades, confusion over the names and definitions of phacomatosis spilorosea, phacomatosis melanorosea, and their defining nevi, as well as of unclassifi- able phacomatosis pigmentovascularis cases, has led to several misplaced diagnoses in published cases. Methods: A systematic and critical review of the worldwide literature on phacomatosis spilorosea and phacomatosis melanorosea was carried out. Results: This study yielded 18 definite instances of phacomatosis spilorosea and 14 of phacomatosis melanorosea, with one and six previously unrecognized cases, respectively. Conclusions: Phacomatosis spilorosea predominantly involves the musculoskeletal system and can be complicated by neuro- logical manifestations. Phacomatosis melanorosea is sometimes associated with ancillary cutaneous lesions, displays a relevant association with vascular malformations of the brain, and in general appears to be a less severe syndrome.
    [Show full text]
  • Understanding the Molecular Mechanism of Phytoconstituents As
    Saudi Journal of Medical and Pharmaceutical Sciences Abbreviated Key Title: Saudi J Med Pharm Sci ISSN 2413-4929 (Print) |ISSN 2413-4910 (Online) Scholars Middle East Publishers, Dubai, United Arab Emirates Journal homepage: https://saudijournals.com Review Article Understanding the Molecular Mechanism of Phytoconstituents as Tyrosinase Inhibitors for Treatment of Hyperpigmentation Lata Kothapalli1*, Pooja Sawant2, AshaThomas1, Ravindra Wavhale1, Komal Bhosale2 1Faculty, Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Gaikwad Haraibhau Vinayan Rd, Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra 411018, India 2Research Scholar, Department of Pharmaceutical Quality Assurance, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Gaikwad Haraibhau Vinayan Rd, Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra 411018, India DOI: 10.36348/sjmps.2021.v07i02.010 | Received: 08.01.2021 | Accepted: 20.01.2021 | Published: 27.02.2021 *Corresponding author: Lata Kothapalli Abstract Skin Pigmentation is a phenomenon in which the accumulation of melanin occurs due to various factors and leads to skin tanning and other skin disorders. Now a day’s human beings are more conscious about quality of life and appearance. With this fascination towards various skin whitening or glowing agents is gaining more adherences. While synthetic chemicals approved as skin whitening agents have got the due recognition in market, the possible adverse effects on sensitive skin creates a question regarding their use. The natural plant extracts available as tyrosinase inhibitors are mostly phenolic entities. In this review the inhibitory effect of phenolic compound and flavonoids on tyrosinase enzyme using molecular simulations is studied. The insilico study of flavonoids helps to predict the mechanism of inhibition as well as identification of potential natural tyrosinase inhibitors.
    [Show full text]
  • Cell Salts for Common Ailments-1
    . Cell Salts for Common Complaints Kristen Santangelo, CCH, RSHom(NA) What are Cell Salts? •12 Non-toxic mineral Compounds present as building blocks in the bodies tissues. • A deficiency of a substance creates symptoms. •Aid in the assimilation of nutrients. •Minerals are highly absorbable. •Focus on physical complaints. History Early to mid 1800’s - Advances in understandings in cell theory. Cells were the simplest units of life and replicated by division. Dr. Rudolf Virchow, the “father of modern pathology” publishes Cellular Pathology. Helping to develop the principles of cell theory. Cells can become diseased and cause dysfunction. Described and named a number of diseases. Jacob Moleschott, Dutch physiologist – In order for structure and vitality of organs to be maintained they must be nourished by inorganic compounds. History Biochemic System of Healing- developed by Wilhelm Heinrich Schuessler (1821-1898). Diseases arise out of a deficiency of inorganic substance that make up the blood and tissues, replenishing the deficiency will heal the disease. Schuessler examined cremated remains to determine the building blocks of the body. 1872- Schuessler announced his theory and system of Biochemics- a mix of- homeopathy and allopathy. Deficiencies in any of the tissue salts would lead to illness and dysfunction. (The Healing Echo, V. McCabe) Why use cell salts? • Safe, effective and gentle. •Simplicity. •Quick dissolve tablets. •Nourish and replenish - medicinal and nutritional. Dosing with cell salts •Use one at a time, in combination or alternated. •7yrs and older - 4 tablets per dose. •Child age 2-6: 2 tablets per dose. •Acute- every ½ to 2 hours during the acute.
    [Show full text]
  • Metastasizing Melanoma Formation Caused by Expression of Activated N-Rasq61k on an Ink4a-Deficient Background
    Research Article Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61K on an INK4a-Deficient Background Julien Ackermann,1 Manon Frutschi,1 Kostas Kaloulis,1 Thomas McKee,2 Andreas Trumpp,1 and Friedrich Beermann1 1ISREC, Swiss Institute for Experimental Cancer Research, National Center of Competence in Research Molecular Oncology, Epalinges, Switzerland and 2Institute of Pathology, University of Lausanne, Lausanne, Switzerland Abstract the most common factors predisposing to melanoma formation in humans is the INK4a/ARF locus (4), which is inactivated with high In human cutaneous malignant melanoma, a predominance of frequency in human melanoma. This locus encodes two distinct activated mutations in the N-ras gene has been documented. INK4a ARF ARF To obtain a mouse model most closely mimicking the human proteins by alternative exon usage, p16 and p14 (p19 in disease, a transgenic mouse line was generated by targeting mice), which function as tumor suppressor genes in the pRB and expression of dominant-active human N-ras (N-RasQ61K) to the p53 pathways, respectively (4, 5). Gene-targeted mice, where p16INK4a and p19ARF are deleted, develop a large variety of tumors melanocyte lineage by tyrosinase regulatory sequences INK4a Q61K but fail to develop melanoma (6). Mice deficient in p16 but (Tyr::N-Ras ). Transgenic mice show hyperpigmented skin ARF and develop cutaneous metastasizing melanoma. Consistent which retain one copy of p19 show carcinogen-induced with the tumor suppressor function of the INK4a locus that susceptibility to metastatic melanoma (7, 8). Transgenic mice that encodes p16INK4A and p19ARF, >90% of Tyr::N-RasQ61K INK4aÀ/À express a mutant form of H-ras specifically in melanocytes showed melanocytic hyperplasia with intense skin pigmentation (9), which transgenic mice develop melanoma at 6 months.
    [Show full text]
  • Hutchinson's Melanotic Freckle
    Hutchiso’s elaotic freckle Also known as Lentigo maligna What is lentigo maligna? Lentigo maligna is an early form of melanoma. In lentigo maligna the cancer cells are confined to the upper layer of the skin (epidermis). When the cancer cells spread deeper into the skin (to dermis) it is called lentigo maligna melanoma. Lentigo maligna occurs most commonly in sun damaged areas such as the face and neck in fair skinned people over the age of 60. The lesion grows slowly in size over a number of years. Melanoma is a potentially lethal disease and lentigo maligna should be diagnosed and excised as soon as possible. What causes lentigo maligna? The cause of lentigo maligna is sun exposure or solarium use. Factors that predispose a person to developing lentigo maligna or associated condition include: . chronic sun damaged/solar-induced skin damage . fair skin complexion . male gender . a personal history of non melanoma skin cancer and precancerous lesions . older individuals (those between 60 to 80 years are most commonly affected) What does lentigo maligna look like? Lentigo maligna commonly looks like a freckle, age spot, sun spot or brown patch that slowly changes shape and grows in size. The spot may be large in size, irregularly shaped with a smooth surface, and of multiple shades of brown and sometimes other colours. Thickening of part of the lesion, increasing number of colours, ulceration or bleeding can be markers that the lesion is changing into a lentigo maligna melanoma. How is lentigo maligna diagnosed? Lentigo maligna is diagnosed clinically by a dermatologist, sometimes with the help of a dermatoscope (a tool used to magnify and look closely at skin moles).
    [Show full text]
  • Pigmented Contact Dermatitis and Chemical Depigmentation
    18_319_334* 05.11.2005 10:30 Uhr Seite 319 Chapter 18 Pigmented Contact Dermatitis 18 and Chemical Depigmentation Hideo Nakayama Contents ca, often occurs without showing any positive mani- 18.1 Hyperpigmentation Associated festations of dermatitis such as marked erythema, with Contact Dermatitis . 319 vesiculation, swelling, papules, rough skin or scaling. 18.1.1 Classification . 319 Therefore, patients may complain only of a pigmen- 18.1.2 Pigmented Contact Dermatitis . 320 tary disorder, even though the disease is entirely the 18.1.2.1 History and Causative Agents . 320 result of allergic contact dermatitis. Hyperpigmenta- 18.1.2.2 Differential Diagnosis . 323 tion caused by incontinentia pigmenti histologica 18.1.2.3 Prevention and Treatment . 323 has often been called a lichenoid reaction, since the 18.1.3 Pigmented Cosmetic Dermatitis . 324 presence of basal liquefaction degeneration, the ac- 18.1.3.1 Signs . 324 cumulation of melanin pigment, and the mononucle- 18.1.3.2 Causative Allergens . 325 ar cell infiltrate in the upper dermis are very similar 18.1.3.3 Treatment . 326 to the histopathological manifestations of lichen pla- 18.1.4 Purpuric Dermatitis . 328 nus. However, compared with typical lichen planus, 18.1.5 “Dirty Neck” of Atopic Eczema . 329 hyperkeratosis is usually milder, hypergranulosis 18.2 Depigmentation from Contact and saw-tooth-shape acanthosis are lacking, hyaline with Chemicals . 330 bodies are hardly seen, and the band-like massive in- 18.2.1 Mechanism of Leukoderma filtration with lymphocytes and histiocytes is lack- due to Chemicals . 330 ing. 18.2.2 Contact Leukoderma Caused Mainly by Contact Sensitization .
    [Show full text]
  • Laser Treatment for Pigmentation
    Laser treatment for pigmentation Sunspots and freckles In lesions such as solar lentigines (sun induced age spots), lentigo simplex and ephelides (freckles) the pigment (melanin) is in the top layers of the skin. Many lasers that selectively target melanin or simply remove the top layers will lead to improvement. One to two treatments will be necessary. There are many non-laser treatment approaches to treat such spots. However, if laser therapy is chosen, there are many different types of laser that can be used including Q-switched lasers [Q switched (QS) alexandrite, QS ruby (694nm)], long-pulsed, fractionated thulium (1927nm) and ablative lasers. IPL (filter 500-600nm) can also be very effective. However, it is common to see the pigmentation return over time. Treatments need to be avoided if the skin is tanned because this greatly increases the risk of complications. Seborrhoeic warts and dermatosis papulosa nigra Some conditions that present as dark spots are in fact wart-like and sit on the surface of the skin such as seborhoeic keratoses and dermatosis papulosa nigra and epidermal naevi. These conditions require physical removal. This is most commonly treated with a curette if thick or with fine wire diathermy particularly for the dermatosis papulosa nigra. Ablative lasers may also be used including CO2 in combination with a curette or an erbium YAG laser which reliably gives the best results. These lesions have a tendency to return over a number of years and maintenance treatments may be needed. Pigmented birth marks – Becker’s naevus Current lasers are unable to remove pigmented birthmarks without scarring.
    [Show full text]